本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ocular Therapeutix

10.16
+0.28502.89%
成交量:88.82萬
成交額:917.69萬
市值:22.23億
市盈率:-7.18
高:10.55
開:10.09
低:10.06
收:9.87
52周最高:16.44
52周最低:6.23
股本:2.19億
流通股本:1.85億
量比:0.66
換手率:0.48%
股息:- -
股息率:- -
每股收益(TTM):-1.4140
每股收益(LYR):-1.4203
淨資產收益率:-72.99%
總資產收益率:-34.95%
市淨率:4.27
市盈率(LYR):-7.15

資料載入中...

2024/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

重要事件披露

Form 8-K - Current report
2024/10/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/09

重要事件披露

Form 8-K - Current report
2024/09/03

重要事件披露

Form 8-K - Current report
2024/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/08/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities